Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

0.8971 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

March 10, 2023

We're starting the final day of the week with a breakdown of the biggest pre-market stock movers worth watching on Friday!

Via InvestorPlace

Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript ↗

March 01, 2023

INO earnings call for the period ending December 31, 2022.

Via The Motley Fool

Why Inovio (INO) Shares Are Moving After-Hours ↗

March 01, 2023

After falling initially in after-hours trading on Wednesday, Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are back up following the company report of worse-than-expected fourth-quarter financial...

Via Benzinga

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

2 Stocks to Sell or Remove From Your Watchlist in 2023 ↗

February 28, 2023

Both stocks soared during the coronavirus vaccine race, but their time has passed.

Via The Motley Fool

Inovio Pharmaceuticals (INO) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

INO earnings call for the period ending September 30, 2022.

Via The Motley Fool

Why Inovio Pharmaceuticals' Shares Jumped 17.31% on Monday ↗

October 17, 2022

The stock jumped Monday despite no news from the company.

Via The Motley Fool

Inovio Pharma Highlights Early Data From Experimental Drug For Respiratory Tract Disease ↗

October 13, 2022

Via Benzinga

Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola ↗

February 02, 2023

Inovio Pharmaceuticals Inc (NASDAQ: INO) announced results from a Phase 1b trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a...

Via Benzinga

3 Sorry Pharma Stocks to Sell in February Before It’s Too Late ↗

February 01, 2023

These are the pharma stocks to sell, as they represent companies with weak fundamentals and sustained cash burn visibility.

Via InvestorPlace

INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates ↗

January 31, 2023

Via Benzinga

If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now ↗

January 10, 2023

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two and a half years. But there was no question some big-name stocks performed...

Via Benzinga

Futu Holdings, UP Fintech Holding And Some Other Big Stocks Moving Lower On Friday ↗

December 30, 2022

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

December 22, 2022

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. Westrock Coffee Company, LLC (NASDAQ: WEST) shares tumbled 10.9% to $11.90...

Via Benzinga

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small...

Via Benzinga

Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket ↗

December 19, 2022

Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in...

Via Benzinga

Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs ↗

November 18, 2022

Via Benzinga

3 Stocks to Avoid Right Now ↗

November 17, 2022

Even though many stocks have fallen sharply in price, not all are bargains -- investors must remains selective.

Via The Motley Fool

While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants

November 16, 2022

EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END

Via FinancialNewsMedia

Why Inovio Pharmaceuticals Stock Is Popping Off ↗

November 09, 2022

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher by 9.11% to $2.34 after the company reported third-quarter financi

Via Benzinga

What's Going On With Inovio Pharmaceuticals Stock Tuesday After Hours ↗

November 08, 2022

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading marginally lower by 0.93% to $2.12 after the company reported

Via Benzinga

Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa ↗

November 03, 2022

Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases...

Via Benzinga

Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today ↗

October 28, 2022

The biotech is ceasing its internally funded efforts to develop a heterologous coronavirus booster.

Via The Motley Fool

Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster ↗

October 28, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

Philips, Owens & Minor And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

October 12, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Tesla, Credit Suisse And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

October 03, 2022

U.S. stock futures traded mixed this morning after recording losses for the third quarter. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed ↗

August 26, 2022

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.